Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

Paramount Global Revenue

Shandong Lukang Pharmaceutical had revenue of 1.67B CNY in the quarter ending March 31, 2025, a decrease of -6.95%. This brings the company's revenue in the last twelve months to 6.11B, down -2.67% year-over-year. In the year 2024, Shandong Lukang Pharmaceutical had annual revenue of 6.23B with 1.41% growth.

• Revenue (ttm): 6.11B
• Revenue Growth: -2.67%
• P/S Ratio: 1.51
• Revenue / Employee: 956.18K
• Employees: 6,388
• Market Cap: 9.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.23B	86.37M	1.41%
Dec 31, 2023	6.15B	525.28M	9.34%
Dec 31, 2022	5.62B	697.66M	14.17%
Dec 31, 2021	4.92B	718.67M	17.09%
Dec 31, 2020	4.21B	472.39M	12.66%